BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND TFRC, P02786, 7037, ENSG00000072274, TFR1, CD71
26 results:

  • 1. Anemia, Iron Deficiency, and Iron Regulators in pancreatic Ductal Adenocarcinoma Patients: A Comprehensive Analysis.
    Osmola M; Gierej B; Mleczko-Sanecka K; Jończy A; Ciepiela O; Kraj L; Ziarkiewicz-Wróblewska B; Basak GW
    Curr Oncol; 2023 Aug; 30(8):7722-7739. PubMed ID: 37623041
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Artemisia argyi H.Lév. & Vaniot essential oil induces ferroptosis in pancreatic cancer cells via up-regulation of tfr1 and depletion of γ-glutamyl cycle.
    Zhang N; Zhang J; Cui W; Wu D; Zhang J; Wei B; Qu L; Xu X
    Fitoterapia; 2023 Jul; 168():105522. PubMed ID: 37169131
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis.
    Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J
    J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Ferroptosis model system by the re-expression of BACH1.
    Irikura R; Nishizawa H; Nakajima K; Yamanaka M; Chen G; Tanaka K; Onodera M; Matsumoto M; Igarashi K
    J Biochem; 2023 Jul; 174(3):239-252. PubMed ID: 37094356
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Aptamer and Peptide-Engineered Polydopamine Nanospheres for Target Delivery and Tumor Perfusion in Synergistic Chemo-Phototherapy of pancreatic cancer.
    Liu L; Xiao X; Guo J; Wang J; Liu S; Wang M; Peng Q; Jiang N
    ACS Appl Mater Interfaces; 2023 Apr; 15(13):16539-16551. PubMed ID: 36961248
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Upregulation of SOCS2 causes mitochondrial dysfunction and promotes ferroptosis in pancreatic cancer cells.
    He M; Cai Y; Yuan Z; Zhang L; Lu H
    Acta Biochim Pol; 2023 Feb; 70(1):163-168. PubMed ID: 36735705
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. KLF14 regulates the growth of hepatocellular carcinoma cells via its modulation of iron homeostasis through the repression of iron-responsive element-binding protein 2.
    Zhou H; Chen J; Fan M; Cai H; Dong Y; Qiu Y; Zhuang Q; Lei Z; Li M; Ding X; Yan P; Lin A; Zheng S; Yan Q
    J Exp Clin Cancer Res; 2023 Jan; 42(1):5. PubMed ID: 36600258
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells.
    Brogyányi T; Kaplánek R; Kejík Z; Hosnedlová B; Antonyová V; Abramenko N; Veselá K; Martásek P; Vokurka M; Richardson DR; Jakubek M
    Biomed Pharmacother; 2022 Nov; 155():113736. PubMed ID: 36156366
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.
    Julián-Serrano S; Yuan F; Wheeler W; Benyamin B; Machiela MJ; Arslan AA; Beane-Freeman LE; Bracci PM; Duell EJ; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Marchand LL; Neale RE; Shu XO; Van Den Eeden SK; Visvanathan K; Zheng W; Albanes D; Andreotti G; Ardanaz E; Babic A; Berndt SI; Brais LK; Brennan P; Bueno-de-Mesquita B; Buring JE; Chanock SJ; Childs EJ; Chung CC; Fabiánová E; Foretová L; Fuchs CS; Gaziano JM; Gentiluomo M; Giovannucci EL; Goggins MG; Hackert T; Hartge P; Hassan MM; Holcátová I; Holly EA; Hung RI; Janout V; Kurtz RC; Lee IM; Malats N; McKean D; Milne RL; Newton CC; Oberg AL; Perdomo S; Peters U; Porta M; Rothman N; Schulze MB; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Weiderpass E; Wenstzensen N; White E; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Zhong J; Kraft P; Li D; Campbell PT; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Klein AP; Yu K; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2021 Oct; 114(4):1408-1417. PubMed ID: 34258619
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Chlorogenic acid depresses cellular bioenergetics to suppress pancreatic carcinoma through modulating c-Myc-tfr1 axis.
    Yang H; Said AM; Huang H; Papa APD; Jin G; Wu S; Ma N; Lan L; Shangguan F; Zhang Q
    Phytother Res; 2021 Apr; 35(4):2200-2210. PubMed ID: 33258205
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells.
    Bai T; Lei P; Zhou H; Liang R; Zhu R; Wang W; Zhou L; Sun Y
    J Cell Mol Med; 2019 Nov; 23(11):7349-7359. PubMed ID: 31507082
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Elucidation and Structural Modeling of cd71 as a Molecular Target for Cell-Specific Aptamer Binding.
    Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
    J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs pancreatic Tumor Growth.
    Lang J; Zhao X; Wang X; Zhao Y; Li Y; Zhao R; Cheng K; Li Y; Han X; Zheng X; Qin H; Geranpayehvaghei M; Shi J; Anderson GJ; Hao J; Ren H; Nie G
    ACS Nano; 2019 Feb; 13(2):2176-2189. PubMed ID: 30676731
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Identification of stable housekeeping genes in response to ionizing radiation in cancer research.
    Iyer G; Wang AR; Brennan SR; Bourgeois S; Armstrong E; Shah P; Harari PM
    Sci Rep; 2017 Mar; 7():43763. PubMed ID: 28262749
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression.
    Lei Y; Hamada Y; Li J; Cong L; Wang N; Li Y; Zheng W; Jiang X
    J Control Release; 2016 Jun; 232():131-42. PubMed ID: 27046157
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transferrin receptor regulates pancreatic cancer growth by modulating mitochondrial respiration and ROS generation.
    Jeong SM; Hwang S; Seong RH
    Biochem Biophys Res Commun; 2016 Mar; 471(3):373-9. PubMed ID: 26869514
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Using Quantitative Seroproteomics to Identify Antibody Biomarkers in pancreatic cancer.
    Jhaveri DT; Kim MS; Thompson ED; Huang L; Sharma R; Klein AP; Zheng L; Le DT; Laheru DA; Pandey A; Jaffee EM; Anders RA
    Cancer Immunol Res; 2016 Mar; 4(3):225-33. PubMed ID: 26842750
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Methylation-associated partial down-regulation of mesothelin causes resistance to anti-mesothelin immunotoxins in a pancreatic cancer cell line.
    Hollevoet K; Mason-Osann E; Müller F; Pastan I
    PLoS One; 2015; 10(3):e0122462. PubMed ID: 25803818
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. SIRT3 regulates cellular iron metabolism and cancer growth by repressing iron regulatory protein 1.
    Jeong SM; Lee J; Finley LW; Schmidt PJ; Fleming MD; Haigis MC
    Oncogene; 2015 Apr; 34(16):2115-24. PubMed ID: 24909164
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for in vivo photodynamic therapy of leukemia.
    Barth BM; I Altinoğlu E; Shanmugavelandy SS; Kaiser JM; Crespo-Gonzalez D; DiVittore NA; McGovern C; Goff TM; Keasey NR; Adair JH; Loughran TP; Claxton DF; Kester M
    ACS Nano; 2011 Jul; 5(7):5325-37. PubMed ID: 21675727
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.